Search Results - "Mattlener, Julia"
-
1
Tripartite antigen-agnostic combination immunotherapy cures established poorly immunogenic tumors
Published in Journal for immunotherapy of cancer (01-10-2022)“…BackgroundSingle-agent immunotherapy has shown remarkable efficacy in selected cancer entities and individual patients. However, most patients fail to respond…”
Get full text
Journal Article -
2
P046: Preclinical evaluation of novel repurposed drug combinations in Hodgkin lymphoma
Published in HemaSphere (03-10-2022)Get full text
Journal Article -
3
S236: HIGH-BREADTH SEQUENCING OF CIRCULATING TUMOR DNA IDENTIFIES NOVEL CLASSIFICATION OF HODGKIN LYMPHOMA
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
4
P037: High breadth whole exome sequencing of circulating tumor DNA identifies novel recurrent genetic alterations in Hodgkin lymphoma
Published in HemaSphere (03-10-2022)Get full text
Journal Article -
5
-
6
Clinical applications of circulating tumor DNA in Hodgkin lymphoma
Published in Seminars in hematology (01-07-2023)“…Hodgkin lymphoma is a B-cell lymphoma often affecting young adults. Outcomes following intensive chemo- and radiotherapy are generally favourable but leave…”
Get full text
Journal Article -
7
Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA
Published in Blood (08-02-2024)“…•Tumor-agnostic ctDNA sequencing in CNSL is feasible and allows for detection of PRD.•We propose the molecular prognostic index for CNSL, a model integrating…”
Get full text
Journal Article -
8
Noninvasive, Dynamic Risk Profiling of Primary Central Nervous System Lymphoma By Peripheral Blood Ctdna-Sequencing
Published in Blood (15-11-2022)Get full text
Journal Article -
9
Circulating Tumor DNA Sequencing for Biologic Classification and Individualized Risk Stratification in Patients With Hodgkin Lymphoma
Published in Journal of clinical oncology (30-09-2024)“…Current clinical challenges in Hodgkin lymphoma (HL) include difficult-to-treat relapsed/refractory disease and considerable long-term toxicities of treatment…”
Get full text
Journal Article -
10
Noninvasive minimal residual disease assessment in relapsed/refractory large B‐cell lymphoma using digital droplet PCR
Published in European journal of haematology (01-06-2024)“…Although several promising approaches for the treatment of relapsed/refractory diffuse large B‐cell lymphoma (rrDLBCL) have been approved recently, it remains…”
Get full text
Journal Article -
11
-
12
S236: HIGH‐BREADTH SEQUENCING OF CIRCULATING TUMOR DNA IDENTIFIES NOVEL CLASSIFICATION OF HODGKIN LYMPHOMA
Published in HemaSphere (01-08-2023)Get full text
Journal Article